EMPACON MET 5/500 TABLET

Product Description

EMPACON MET 5/500 TABLETEmpagliflozin 5 mg + Metformin Hydrochloride 500 mgProduct Description: EMPACON MET 5/500 TABLET is a high-quality oral antidiabetic medication formulated with Empagliflozin 5 mg and Metformin Hydrochloride 500 mg, designed to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. Manufactured under strict pharmaceutical standards, this combination therapy supports improved insulin sensitivity, reduced glucose absorption, and enhanced urinary glucose excretion.Key Benefits: Dual-action formula for optimal blood sugar management Helps reduce HbA1c levels and improve metabolic outcomes Supports weight control and cardiovascular health in diabetic patients Convenient once/twice daily dosing enhances patient compliance Usage/Application: Recommended as part of a comprehensive diabetes management plan including diet and exercise, EMPACON MET 5/500 TABLET is suitable for adult patients requiring combination therapy for improved glycemic control.Composition: Empagliflozin 5 mg Metformin Hydrochloride 500 mg Excipients q.s. Colour: Approved colour used Target Buyers: Ideal for pharmaceutical distributors, hospital supply chains, diabetic care retailers, and bulk medicine buyers looking for trusted, efficacious diabetes control formulations. Availability: Ready for bulk orders, private labeling, and distributor partnerships across India and global export markets.